E4402 – Randomized Phase III Trial Comparing Two Different Rituximab Dosing Regimens for Patients with Low Tumor Burden Indolent non-Hodgkin’s Lymphoma
Physician and Research Staff Educational Materials:
Patient Educational Materials:
- Patient FAQs: frequently asked questions from patients about treatment, eligibility criteria, and potential enrollment issues, with answers in lay language.
Additional Information at ClinicalTrials.gov: